Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,856
Total Claims
$2.0M
Drug Cost
792
Beneficiaries
$2,468
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-68%
Opioid rate vs peers
0.7% vs 2.2% avg
+75%
Cost per patient vs peers
$2,468 vs $1,411 avg
+24%
Brand preference vs peers
13.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.7%
Opioid Rate
165
Opioid Claims
$3,682
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,996 claims · $1.5M
Generic: 19,758 claims · $482K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 471 | $158K |
| Empagliflozin | 202 | $139K |
| Sitagliptin Phosphate | 95 | $90K |
| Rivaroxaban | 140 | $81K |
| Linagliptin | 167 | $63K |
| Dapagliflozin Propanediol | 38 | $59K |
| Mirabegron | 100 | $52K |
| Semaglutide | 36 | $48K |
| Insulin Glargine,hum.Rec.Anlog | 88 | $38K |
| Dextromethorphan Hbr/Quinidine | 24 | $38K |
| Teriparatide | 13 | $35K |
| Fluticasone/Umeclidin/Vilanter | 52 | $33K |
| Dulaglutide | 23 | $32K |
| Insulin Lispro Protamin/Lispro | 24 | $30K |
| Sitagliptin Phos/Metformin Hcl | 15 | $25K |
Prescribing Profile
Patient Profile
75
Avg Age
50%
Female
1.65
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About